Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
7 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Merck & Co.'s KEYTRUDA QLEX (pembrolizumab and berahyaluronidase alfa-pmph) injection for subcutaneous use has been approved by Japan's Ministry of Health, Labor and Welfare for all indications previously approved for KEYTRUDA. KEYJECT, the planned trademark for KEYTRUDA QLEX in Japan, can be administered in as little
On Wednesday, GRAIL (NASDAQ: GRAL ) discussed second-quarter financial results during its earnings call. The full transcript is provided below. This content is powered APIs. For comprehensive financial data and transcripts, visit The full earnings call is available at Summary GRAIL reported a strong second quarter 2026
***General Trend and Developments*** -Overall Asian equities are again directionless ahead of the upcoming US-related events. Cautious start to the new quarter? - Disappointing PMIs seen throughout Asia [including China, Indonesia, Japan, South Korea, Taiwan, Vietnam]. The Chinese data was hurt by new export orders. -S
**All times listed for economic events are denominated in Eastern Standard Time (Add 4 hours for GMT equivalent) *** As always times are subject to change *** - 19:00 (AU) Australia Jun Final PMI Manufacturing: No est v 51.2 prelim - 19:50 (JP) Japan Q2 Tankan Large Manufacturing Index: 16e v 17 prior; Large Manufactur
**All times listed for economic events are denominated in Eastern Standard Time (Add 4 hours for GMT equivalent) ***As always times are subject to change*** **Economic data** - 01:00 (FI) Finland Jun Consumer Confidence: No est v -10.5 prior; Business Confidence: No est v 3 prior - 02:00 (SE) Sweden May Trade Balance (
Japan PM Takaichi Cabinet approval rating remains unchanged at 60% in Asahi poll
Japan PM Takaichi Cabinet approval rating remains unchanged at 60% in Asahi poll